CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-15 | Baroldi Joseph EVP, Chief Business Officer | Exercise or conversion | +8,787 | 28,418 | ||
| 2025-01-15 | Baroldi Joseph EVP, Chief Business Officer | Exercise or conversion | +2,460 | 4,100 | ||
| 2025-01-15 | Baroldi Joseph EVP, Chief Business Officer | Grant or award · Performance Restricted Stock Units | +22,000 | 51,290 | ||
| 2025-01-15 | Baroldi Joseph EVP, Chief Business Officer | Grant or award · Restricted Stock Unit | +33,000 | 86,135 | ||
| 2025-01-15 | Baroldi Joseph EVP, Chief Business Officer | Exercise or conversion · Restricted Stock Unit | −8,787 | 77,348 | ||
| 2025-01-15 | Baroldi Joseph EVP, Chief Business Officer | Grant or award · Restricted Stock Unit | +3,750 | 10,784 | ||
| 2025-01-15 | Baroldi Joseph EVP, Chief Business Officer | Exercise or conversion · Restricted Stock Unit | −2,460 | 8,324 | ||
| 2025-01-02 | Geary Richard S EVP, Chief Development Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2025-01-02 | Swayze Eric EVP Research | Grant or award · Non-Qualified Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2025-01-02 | Swayze Eric EVP Research | Grant or award · Non-Qualified Stock Option (right to buy) | +163 | 163 | ||
| 2025-01-02 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Grant or award · Non-Qualified Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2025-01-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Grant or award · Non-Qualified Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2025-01-02 | Monia Brett P Chief Executive Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +86,263 | 86,263 | ||
| 2025-01-02 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Grant or award · Non-Qualified Stock Option (right to buy) | +18,700 | 18,700 | ||
| 2025-01-02 | HOUGEN ELIZABETH L EVP, Finance & CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +31,000 | 31,000 | ||
| 2025-01-02 | Devers Shannon L. EVP, Chief Human Resources Ofc | Grant or award · Non-Qualified Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2025-01-02 | Birchler Brian EVP, Corp and Development Ops | Grant or award · Non-Qualified Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2025-01-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2025-01-02 | Baroldi Joseph EVP, Chief Business Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2025-01-02 | Baroldi Joseph EVP, Chief Business Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +2,500 | 2,500 |
Page 35 of 44 · 873 trades